GLP-1 Price Guide Compare prices
Compounded Semaglutide · June 1, 2026

Compounded Semaglutide Online: What Patients Should Know

With the FDA semaglutide shortage resolved and the 2026 regulatory framework tightening, patients need to know more before choosing an online compounded program.

Compounded SemaglutideJune 1, 2026Editorial
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework

The 2026 Landscape

Compounded semaglutide remains available through licensed telehealth providers and licensed compounding pharmacies. Key changes since 2024:

Compounded semaglutide is not FDA-approved as a finished drug product. It is not bioequivalent to Wegovy or Ozempic in the FDA-regulatory sense.

What Patients Should Verify

  1. Provider requires patient-specific clinical evaluation before prescribing
  2. Prescriber is licensed in your state
  3. Partner pharmacy is named and licensed
  4. Maintenance-dose monthly price is disclosed pre-purchase
  5. No FDA-approval or brand-equivalence claims in marketing

Frequently asked questions

Is compounded semaglutide still legal in 2026?
Yes — through patient-specific prescribing by a licensed clinician dispensed by a licensed 503A or 503B compounding pharmacy. The shortage-era allowances are no longer in effect, but standard 503A/503B compounding authorities remain.

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.